Ethics. Research. Community.

The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Stem cells translational medicine. 
2
(10): 
727-730; 
2013. 
(English). 
[Record Source: PubMed]
Human somatic cell reprogramming is a leading technology for accelerating disease modeling and drug discovery. Research organizations are sponsoring initiatives to create libraries of induced pluripotent stem cell (iPSC) lines for broad distribution and application. Donor informed consent plays a critical role in supporting the ethical conduct of iPSC research. To date, our organizations have focused on informed consent considerations for somatic cell collection intended specifically for iPSC derivation and distribution. This article considers how somatic cells obtained under general (biomedical) research protocols can be used for iPSC derivation. We present draft Points to Consider regarding the use of human somatic cells for iPSC research. Our goal is to initiate a process designed to develop consensus for the use of previously collected specimens for iPSC research. We anticipate publishing final considerations in early 2014.
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeJournal Article
Record Source Status
[MEDLINE]
FormatsPrint-Electronic
LicenseNone (All rights reserved) ©
DOI10.5966/sctm.2013-0099
ISSN2157-6564